- call +1-201-465-4211
- email sales@marketsandresearch.biz
- Call +1-201-465-4211
- Email: sales@marketsandresearch.biz
According to this study, over the next five years the Felodipine Sustained-Release Tablet market will register a xx%% CAGR in terms of revenue, the global market size will reach $ xx million by 2025, from $ xx million in 2019. In particular, this report presents the global market share (sales and revenue) of key companies in Felodipine Sustained-Release Tablet business, shared in Chapter 3.
This report presents a comprehensive overview, market shares, and growth opportunities of Felodipine Sustained-Release Tablet market by product type, application, key manufacturers and key regions and countries.
This study specially analyses the impact of Covid-19 outbreak on the Felodipine Sustained-Release Tablet, covering the supply chain analysis, impact assessment to the Felodipine Sustained-Release Tablet market size growth rate in several scenarios, and the measures to be undertaken by Felodipine Sustained-Release Tablet companies in response to the COVID-19 epidemic.
Segmentation by type: breakdown data from 2015 to 2020, in Section 2.3; and forecast to 2025 in section 11.7.
2.5mg Per Tablet
5mg Per Tablet
Others
Segmentation by application: breakdown data from 2015 to 2020, in Section 2.4; and forecast to 2024 in section 11.8.
Treat High Blood Pressure
Relieve Angina
Others
This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report: Breakdown data in in Chapter 3.
Astrazeneca
NanJing Easeheal Phaemaecutical
Lifeon
Changzhou Siyao Pharmaceutical
SHANXI KANGBO BIOLOGICAL PRODUCT
Mylan
Sandoz
In addition, this report discusses the key drivers influencing market growth, opportunities, the challenges and the risks faced by key manufacturers and the market as a whole. It also analyzes key emerging trends and their impact on present and future development.
Research objectives
To study and analyze the global Felodipine Sustained-Release Tablet consumption (value & volume) by key regions/countries, type and application, history data from 2015 to 2019, and forecast to 2025.
To understand the structure of Felodipine Sustained-Release Tablet market by identifying its various subsegments.
Focuses on the key global Felodipine Sustained-Release Tablet manufacturers, to define, describe and analyze the sales volume, value, market share, market competition landscape, SWOT analysis and development plans in next few years.
To analyze the Felodipine Sustained-Release Tablet with respect to individual growth trends, future prospects, and their contribution to the total market.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
To project the consumption of Felodipine Sustained-Release Tablet submarkets, with respect to key regions (along with their respective key countries).
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
To strategically profile the key players and comprehensively analyze their growth strategies.
The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.
Market is segmented on the basis:
The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.
The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.
1 Scope of the Report
1.1 Market Introduction
1.2 Research Objectives
1.3 Years Considered
1.4 Market Research Methodology
1.5 Data Source
1.6 Economic Indicators
1.7 Currency Considered
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Felodipine Sustained-Release Tablet Consumption 2015-2025
2.1.2 Felodipine Sustained-Release Tablet Consumption CAGR by Region
2.2 Felodipine Sustained-Release Tablet Segment by Type
2.2.1 2.5mg Per Tablet
2.2.2 5mg Per Tablet
2.2.3 Others
2.3 Felodipine Sustained-Release Tablet Consumption by Type
2.3.1 Global Felodipine Sustained-Release Tablet Consumption Market Share by Type (2015-2020)
2.3.2 Global Felodipine Sustained-Release Tablet Revenue and Market Share by Type (2015-2020)
2.3.3 Global Felodipine Sustained-Release Tablet Sale Price by Type (2015-2020)
2.4 Felodipine Sustained-Release Tablet Segment by Application
2.4.1 Treat High Blood Pressure
2.4.2 Relieve Angina
2.4.3 Others
2.5 Felodipine Sustained-Release Tablet Consumption by Application
2.5.1 Global Felodipine Sustained-Release Tablet Consumption Market Share by Type (2015-2020)
2.5.2 Global Felodipine Sustained-Release Tablet Value and Market Share by Type (2015-2020)
2.5.3 Global Felodipine Sustained-Release Tablet Sale Price by Type (2015-2020)
3 Global Felodipine Sustained-Release Tablet by Company
3.1 Global Felodipine Sustained-Release Tablet Sales Market Share by Company
3.1.1 Global Felodipine Sustained-Release Tablet Sales by Company (2018-2020)
3.1.2 Global Felodipine Sustained-Release Tablet Sales Market Share by Company (2018-2020)
3.2 Global Felodipine Sustained-Release Tablet Revenue Market Share by Company
3.2.1 Global Felodipine Sustained-Release Tablet Revenue by Company (2018-2020)
3.2.2 Global Felodipine Sustained-Release Tablet Revenue Market Share by Company (2018-2020)
3.3 Global Felodipine Sustained-Release Tablet Sale Price by Company
3.4 Global Felodipine Sustained-Release Tablet Manufacturing Base Distribution, Sales Area, Type by Company
3.4.1 Global Felodipine Sustained-Release Tablet Manufacturing Base Distribution and Sales Area by Company
3.4.2 Players Felodipine Sustained-Release Tablet Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) (2018-2020)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 Felodipine Sustained-Release Tablet by Regions
4.1 Felodipine Sustained-Release Tablet by Regions
4.2 Americas Felodipine Sustained-Release Tablet Consumption Growth
4.3 APAC Felodipine Sustained-Release Tablet Consumption Growth
4.4 Europe Felodipine Sustained-Release Tablet Consumption Growth
4.5 Middle East & Africa Felodipine Sustained-Release Tablet Consumption Growth
5 Americas
5.1 Americas Felodipine Sustained-Release Tablet Consumption by Countries
5.1.1 Americas Felodipine Sustained-Release Tablet Consumption by Countries (2015-2020)
5.1.2 Americas Felodipine Sustained-Release Tablet Value by Countries (2015-2020)
5.2 Americas Felodipine Sustained-Release Tablet Consumption by Type
5.3 Americas Felodipine Sustained-Release Tablet Consumption by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
5.8 Key Economic Indicators of Few Americas Countries
6 APAC
6.1 APAC Felodipine Sustained-Release Tablet Consumption by Regions
6.1.1 APAC Felodipine Sustained-Release Tablet Consumption by Regions (2015-2020)
6.1.2 APAC Felodipine Sustained-Release Tablet Value by Regions (2015-2020)
6.2 APAC Felodipine Sustained-Release Tablet Consumption by Type
6.3 APAC Felodipine Sustained-Release Tablet Consumption by Application
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 Key Economic Indicators of Few APAC Regions
7 Europe
7.1 Europe Felodipine Sustained-Release Tablet by Countries
7.1.1 Europe Felodipine Sustained-Release Tablet Consumption by Countries (2015-2020)
7.1.2 Europe Felodipine Sustained-Release Tablet Value by Countries (2015-2020)
7.2 Europe Felodipine Sustained-Release Tablet Consumption by Type
7.3 Europe Felodipine Sustained-Release Tablet Consumption by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
7.9 Key Economic Indicators of Few Europe Countries
8 Middle East & Africa
8.1 Middle East & Africa Felodipine Sustained-Release Tablet by Countries
8.1.1 Middle East & Africa Felodipine Sustained-Release Tablet Consumption by Countries (2015-2020)
8.1.2 Middle East & Africa Felodipine Sustained-Release Tablet Value by Countries (2015-2020)
8.2 Middle East & Africa Felodipine Sustained-Release Tablet Consumption by Type
8.3 Middle East & Africa Felodipine Sustained-Release Tablet Consumption by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers and Impact
9.1.1 Growing Demand from Key Regions
9.1.2 Growing Demand from Key Applications and Potential Industries
9.2 Market Challenges and Impact
9.3 Market Trends
10 Marketing, Distributors and Customer
10.1 Sales Channel
10.1.1 Direct Channels
10.1.2 Indirect Channels
10.2 Felodipine Sustained-Release Tablet Distributors
10.3 Felodipine Sustained-Release Tablet Customer
11 Global Felodipine Sustained-Release Tablet Market Forecast
11.1 Global Felodipine Sustained-Release Tablet Consumption Forecast (2021-2025)
11.2 Global Felodipine Sustained-Release Tablet Forecast by Regions
11.2.1 Global Felodipine Sustained-Release Tablet Forecast by Regions (2021-2025)
11.2.2 Global Felodipine Sustained-Release Tablet Value Forecast by Regions (2021-2025)
11.2.3 Americas Consumption Forecast
11.2.4 APAC Consumption Forecast
11.2.5 Europe Consumption Forecast
11.2.6 Middle East & Africa Consumption Forecast
11.3 Americas Forecast by Countries
11.3.1 United States Market Forecast
11.3.2 Canada Market Forecast
11.3.3 Mexico Market Forecast
11.3.4 Brazil Market Forecast
11.4 APAC Forecast byRegions
11.4.1 China Market Forecast
11.4.2 Japan Market Forecast
11.4.3 Korea Market Forecast
11.4.4 Southeast Asia Market Forecast
11.4.5 India Market Forecast
11.4.6 Australia Market Forecast
11.5 Europe Forecast by Countries
11.5.1 Germany Market Forecast
11.5.2 France Market Forecast
11.5.3 UK Market Forecast
11.5.4 Italy Market Forecast
11.5.5 Russia Market Forecast
11.6 Middle East & Africa Forecast by Countries
11.6.1 Egypt Market Forecast
11.6.2 South Africa Market Forecast
11.6.3 Israel Market Forecast
11.6.4 Turkey Market Forecast
11.6.5 GCC Countries Market Forecast
11.7 Global Felodipine Sustained-Release Tablet Forecast by Type
11.8 Global Felodipine Sustained-Release Tablet Forecast by Application
12 Key Players Analysis
12.1 Astrazeneca
12.1.1 Company Information
12.1.2 Felodipine Sustained-Release Tablet Product Offered
12.1.3 Astrazeneca Felodipine Sustained-Release Tablet Sales, Revenue, Price and Gross Margin (2018-2020)
12.1.4 Main Business Overview
12.1.5 Astrazeneca Latest Developments
12.2 NanJing Easeheal Phaemaecutical
12.2.1 Company Information
12.2.2 Felodipine Sustained-Release Tablet Product Offered
12.2.3 NanJing Easeheal Phaemaecutical Felodipine Sustained-Release Tablet Sales, Revenue, Price and Gross Margin (2018-2020)
12.2.4 Main Business Overview
12.2.5 NanJing Easeheal Phaemaecutical Latest Developments
12.3 Lifeon
12.3.1 Company Information
12.3.2 Felodipine Sustained-Release Tablet Product Offered
12.3.3 Lifeon Felodipine Sustained-Release Tablet Sales, Revenue, Price and Gross Margin (2018-2020)
12.3.4 Main Business Overview
12.3.5 Lifeon Latest Developments
12.4 Changzhou Siyao Pharmaceutical
12.4.1 Company Information
12.4.2 Felodipine Sustained-Release Tablet Product Offered
12.4.3 Changzhou Siyao Pharmaceutical Felodipine Sustained-Release Tablet Sales, Revenue, Price and Gross Margin (2018-2020)
12.4.4 Main Business Overview
12.4.5 Changzhou Siyao Pharmaceutical Latest Developments
12.5 SHANXI KANGBO BIOLOGICAL PRODUCT
12.5.1 Company Information
12.5.2 Felodipine Sustained-Release Tablet Product Offered
12.5.3 SHANXI KANGBO BIOLOGICAL PRODUCT Felodipine Sustained-Release Tablet Sales, Revenue, Price and Gross Margin (2018-2020)
12.5.4 Main Business Overview
12.5.5 SHANXI KANGBO BIOLOGICAL PRODUCT Latest Developments
12.6 Mylan
12.6.1 Company Information
12.6.2 Felodipine Sustained-Release Tablet Product Offered
12.6.3 Mylan Felodipine Sustained-Release Tablet Sales, Revenue, Price and Gross Margin (2018-2020)
12.6.4 Main Business Overview
12.6.5 Mylan Latest Developments
12.7 Sandoz
12.7.1 Company Information
12.7.2 Felodipine Sustained-Release Tablet Product Offered
12.7.3 Sandoz Felodipine Sustained-Release Tablet Sales, Revenue, Price and Gross Margin (2018-2020)
12.7.4 Main Business Overview
12.7.5 Sandoz Latest Developments
...
13 Research Findings and Conclusion
List of Tables
Table 1. Research Methodology
Table 2. Data Source
Table 3. Felodipine Sustained-Release Tablet Consumption CAGR by Region 2015-2025 ($ Millions)
Table 4. Major Players of 2.5mg Per Tablet
Table 5. Major Players of 5mg Per Tablet
Table 6. Major Players of Others
Table 7. Global Consumption Sales by Type (2015-2020)
Table 8. Global Felodipine Sustained-Release Tablet Consumption Market Share by Type (2015-2020)
Table 9. Global Felodipine Sustained-Release Tablet Revenue by Type (2015-2020) ($ million)
Table 10. Global Felodipine Sustained-Release Tablet Value Market Share by Type (2015-2020) ($ Millions)
Table 11. Global Felodipine Sustained-Release Tablet Sale Price by Type (2015-2020)
Table 12. Global Consumption Sales by Application (2015-2020)
Table 13. Global Felodipine Sustained-Release Tablet Consumption Market Share by Application (2015-2020)
Table 14. Global Felodipine Sustained-Release Tablet Value by Application (2015-2020)
Table 15. Global Felodipine Sustained-Release Tablet Value Market Share by Application (2015-2020)
Table 16. Global Felodipine Sustained-Release Tablet Sale Price by Application (2015-2020)
Table 17. Global Felodipine Sustained-Release Tablet Sales by Company (2017-2019) (K Units)
Table 18. Global Felodipine Sustained-Release Tablet Sales Market Share by Company (2017-2019)
Table 19. Global Felodipine Sustained-Release Tablet Revenue by Company (2017-2019) ($ Millions)
Table 20. Global Felodipine Sustained-Release Tablet Revenue Market Share by Company (2017-2019)
Table 21. Global Felodipine Sustained-Release Tablet Sale Price by Company (2017-2019)
Table 22. Global Felodipine Sustained-Release Tablet Manufacturing Base Distribution and Sales Area by Manufacturers
Table 23. Players Felodipine Sustained-Release Tablet Products Offered
Table 24. Felodipine Sustained-Release Tablet Concentration Ratio (CR3, CR5 and CR10) (2017-2019)
Table 25. Global Felodipine Sustained-Release Tablet Consumption by Regions 2015-2020 (K Units)
Table 26. Global Felodipine Sustained-Release Tablet Consumption Market Share by Regions 2015-2020
Table 27. Global Felodipine Sustained-Release Tablet Value by Regions 2015-2020 ($ Millions)
Table 28. Global Felodipine Sustained-Release Tablet Value Market Share by Regions 2015-2020
Table 29. Americas Felodipine Sustained-Release Tablet Consumption by Countries (2015-2020) (K Units)
Table 30. Americas Felodipine Sustained-Release Tablet Consumption Market Share by Countries (2015-2020)
Table 31. Americas Felodipine Sustained-Release Tablet Value by Countries (2015-2020) ($ Millions)
Table 32. Americas Felodipine Sustained-Release Tablet Value Market Share by Countries (2015-2020)
Table 33. Americas Felodipine Sustained-Release Tablet Consumption by Type (2015-2020) (K Units)
Table 34. Americas Felodipine Sustained-Release Tablet Consumption Market Share by Type (2015-2020)
Table 35. Americas Felodipine Sustained-Release Tablet Consumption by Application (2015-2020) (K Units)
Table 36. Americas Felodipine Sustained-Release Tablet Consumption Market Share by Application (2015-2020)
Table 37. APAC Felodipine Sustained-Release Tablet Consumption by Regions (2015-2020) (K Units)
Table 38. APAC Felodipine Sustained-Release Tablet Consumption Market Share by Regions (2015-2020)
Table 39. APAC Felodipine Sustained-Release Tablet Value by Regions (2015-2020) ($ Millions)
Table 40. APAC Felodipine Sustained-Release Tablet Value Market Share by Regions (2015-2020)
Table 41. APAC Felodipine Sustained-Release Tablet Consumption by Type (2015-2020) (K Units)
Table 42. APAC Felodipine Sustained-Release Tablet Consumption Market Share by Type (2015-2020)
Table 43. APAC Felodipine Sustained-Release Tablet Consumption by Application (2015-2020) (K Units)
Table 44. APAC Felodipine Sustained-Release Tablet Consumption Market Share by Application (2015-2020)
Table 45. Europe Felodipine Sustained-Release Tablet Consumption by Countries (2015-2020) (K Units)
Table 46. Europe Felodipine Sustained-Release Tablet Consumption Market Share by Countries (2015-2020)
Table 47. Europe Felodipine Sustained-Release Tablet Value by Countries (2015-2020) ($ Millions)
Table 48. Europe Felodipine Sustained-Release Tablet Value Market Share by Countries (2015-2020)
Table 49. Europe Felodipine Sustained-Release Tablet Consumption by Type (2015-2020) (K Units)
Table 50. Europe Felodipine Sustained-Release Tablet Consumption Market Share by Type (2015-2020)
Table 51. Europe Felodipine Sustained-Release Tablet Consumption by Application (2015-2020) (K Units)
Table 52. Europe Felodipine Sustained-Release Tablet Consumption Market Share by Application (2015-2020)
Table 53. Middle East & Africa Felodipine Sustained-Release Tablet Consumption by Countries (2015-2020) (K Units)
Table 54. Middle East & Africa Felodipine Sustained-Release Tablet Consumption Market Share by Countries (2015-2020)
Table 55. Middle East & Africa Felodipine Sustained-Release Tablet Value by Countries (2015-2020) ($ Millions)
Table 56. Middle East & Africa Felodipine Sustained-Release Tablet Value Market Share by Countries (2015-2020)
Table 57. Middle East & Africa Felodipine Sustained-Release Tablet Consumption by Type (2015-2020) (K Units)
Table 58. Middle East & Africa Felodipine Sustained-Release Tablet Consumption Market Share by Type (2015-2020)
Table 59. Middle East & Africa Felodipine Sustained-Release Tablet Consumption by Application (2015-2020) (K Units)
Table 60. Middle East & Africa Felodipine Sustained-Release Tablet Consumption Market Share by Application (2015-2020)
Table 61. Felodipine Sustained-Release Tablet Distributors List
Table 62. Felodipine Sustained-Release Tablet Customer List
Table 63. Global Felodipine Sustained-Release Tablet Consumption Forecast by Countries (2021-2025) (K Units)
Table 64. Global Felodipine Sustained-Release Tablet Consumption Market Forecast by Regions
Table 65. Global Felodipine Sustained-Release Tablet Value Forecast by Countries (2021-2025) ($ Millions)
Table 66. Global Felodipine Sustained-Release Tablet Value Market Share Forecast by Regions
Table 67. Global Felodipine Sustained-Release Tablet Consumption Forecast by Type (2021-2025) (K Units)
Table 68. Global Felodipine Sustained-Release Tablet Consumption Market Share Forecast by Type (2021-2025)
Table 69. Global Felodipine Sustained-Release Tablet Value Forecast by Type (2021-2025) ($ Millions)
Table 70. Global Felodipine Sustained-Release Tablet Value Market Share Forecast by Type (2021-2025)
Table 71. Global Felodipine Sustained-Release Tablet Consumption Forecast by Application (2021-2025) (K Units)
Table 72. Global Felodipine Sustained-Release Tablet Consumption Market Share Forecast by Application (2021-2025)
Table 73. Global Felodipine Sustained-Release Tablet Value Forecast by Application (2021-2025) ($ Millions)
Table 74. Global Felodipine Sustained-Release Tablet Value Market Share Forecast by Application (2021-2025)
Table 75. Astrazeneca Product Offered
Table 76. Astrazeneca Felodipine Sustained-Release Tablet Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2020E)
Table 77. Astrazeneca Main Business
Table 78. Astrazeneca Latest Developments
Table 79. Astrazeneca Basic Information, Company Total Revenue (in $ million), Felodipine Sustained-Release Tablet Manufacturing Base, Sales Area and Its Competitors
Table 80. NanJing Easeheal Phaemaecutical Product Offered
Table 81. NanJing Easeheal Phaemaecutical Felodipine Sustained-Release Tablet Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2020E)
Table 82. NanJing Easeheal Phaemaecutical Main Business
Table 83. NanJing Easeheal Phaemaecutical Latest Developments
Table 84. NanJing Easeheal Phaemaecutical Basic Information, Company Total Revenue (in $ million), Felodipine Sustained-Release Tablet Manufacturing Base, Sales Area and Its Competitors
Table 85. Lifeon Product Offered
Table 86. Lifeon Felodipine Sustained-Release Tablet Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2020E)
Table 87. Lifeon Main Business
Table 88. Lifeon Latest Developments
Table 89. Lifeon Basic Information, Company Total Revenue (in $ million), Felodipine Sustained-Release Tablet Manufacturing Base, Sales Area and Its Competitors
Table 90. Changzhou Siyao Pharmaceutical Product Offered
Table 91. Changzhou Siyao Pharmaceutical Felodipine Sustained-Release Tablet Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2020E)
Table 92. Changzhou Siyao Pharmaceutical Main Business
Table 93. Changzhou Siyao Pharmaceutical Latest Developments
Table 94. Changzhou Siyao Pharmaceutical Basic Information, Company Total Revenue (in $ million), Felodipine Sustained-Release Tablet Manufacturing Base, Sales Area and Its Competitors
Table 95. SHANXI KANGBO BIOLOGICAL PRODUCT Product Offered
Table 96. SHANXI KANGBO BIOLOGICAL PRODUCT Felodipine Sustained-Release Tablet Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2020E)
Table 97. SHANXI KANGBO BIOLOGICAL PRODUCT Main Business
Table 98. SHANXI KANGBO BIOLOGICAL PRODUCT Latest Developments
Table 99. SHANXI KANGBO BIOLOGICAL PRODUCT Basic Information, Company Total Revenue (in $ million), Felodipine Sustained-Release Tablet Manufacturing Base, Sales Area and Its Competitors
Table 100. Mylan Product Offered
Table 101. Mylan Felodipine Sustained-Release Tablet Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2020E)
Table 102. Mylan Main Business
Table 103. Mylan Latest Developments
Table 104. Mylan Basic Information, Company Total Revenue (in $ million), Felodipine Sustained-Release Tablet Manufacturing Base, Sales Area and Its Competitors
Table 105. Sandoz Product Offered
Table 106. Sandoz Basic Information, Company Total Revenue (in $ million), Felodipine Sustained-Release Tablet Manufacturing Base, Sales Area and Its Competitors
Table 107. Sandoz Main Business
Table 108. Sandoz Latest Developments
Table 109. Sandoz Felodipine Sustained-Release Tablet Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2020E)
List of Figures
Figure 1. Picture of Felodipine Sustained-Release Tablet
Figure 2. Felodipine Sustained-Release Tablet Report Years Considered
Figure 3. Market Research Methodology
Figure 4. Global Felodipine Sustained-Release Tablet Consumption Growth Rate 2015-2025 (K Units)
Figure 5. Global Felodipine Sustained-Release Tablet Value Growth Rate 2015-2025 ($ Millions)
Figure 6. Product Picture of 2.5mg Per Tablet
Figure 7. Product Picture of 5mg Per Tablet
Figure 8. Product Picture of Others
Figure 9. Global Felodipine Sustained-Release Tablet Consumption Market Share by Type (2015-2020)
Figure 10. Global Felodipine Sustained-Release Tablet Value Market Share by Type (2015-2020)
Figure 11. Felodipine Sustained-Release Tablet Consumed in Treat High Blood Pressure
Figure 12. Global Felodipine Sustained-Release Tablet Market: Treat High Blood Pressure (2015-2020) (K Units)
Figure 13. Global Felodipine Sustained-Release Tablet Market: Treat High Blood Pressure (2015-2020) ($ Millions)
Figure 14. Felodipine Sustained-Release Tablet Consumed in Relieve Angina
Figure 15. Global Felodipine Sustained-Release Tablet Market: Relieve Angina (2015-2020) (K Units)
Figure 16. Global Felodipine Sustained-Release Tablet Market: Relieve Angina (2015-2020) ($ Millions)
Figure 17. Felodipine Sustained-Release Tablet Consumed in Others
Figure 18. Global Felodipine Sustained-Release Tablet Market: Others (2015-2020) (K Units)
Figure 19. Global Felodipine Sustained-Release Tablet Market: Others (2015-2020) ($ Millions)
Figure 20. Global Felodipine Sustained-Release Tablet Consumption Market Share by Application (2015-2020)
Figure 21. Global Felodipine Sustained-Release Tablet Value Market Share by Application (2015-2020)
Figure 22. Global Felodipine Sustained-Release Tablet Sales Market Share by Company in 2017
Figure 23. Global Felodipine Sustained-Release Tablet Sales Market Share by Company in 2019
Figure 24. Global Felodipine Sustained-Release Tablet Revenue Market Share by Company in 2017
Figure 25. Global Felodipine Sustained-Release Tablet Revenue Market Share by Company in 2019
Figure 26. Global Felodipine Sustained-Release Tablet Sale Price by Company in 2019
Figure 27. Global Felodipine Sustained-Release Tablet Consumption Market Share by Regions 2015-2020
Figure 28. Global Felodipine Sustained-Release Tablet Value Market Share by Regions 2015-2020
Figure 29. Americas Felodipine Sustained-Release Tablet Consumption 2015-2020 (K Units)
Figure 30. Americas Felodipine Sustained-Release Tablet Value 2015-2020 ($ Millions)
Figure 31. APAC Felodipine Sustained-Release Tablet Consumption 2015-2020 (K Units)
Figure 32. APAC Felodipine Sustained-Release Tablet Value 2015-2020 ($ Millions)
Figure 33. Europe Felodipine Sustained-Release Tablet Consumption 2015-2020 (K Units)
Figure 34. Europe Felodipine Sustained-Release Tablet Value 2015-2020 ($ Millions)
Figure 35. Middle East & Africa Felodipine Sustained-Release Tablet Consumption 2015-2020 (K Units)
Figure 36. Middle East & Africa Felodipine Sustained-Release Tablet Value 2015-2020 ($ Millions)
Figure 37. Americas Felodipine Sustained-Release Tablet Consumption Market Share by Countries in 2019
Figure 38. Americas Felodipine Sustained-Release Tablet Value Market Share by Countries in 2019
Figure 39. Americas Felodipine Sustained-Release Tablet Consumption Market Share by Type in 2019
Figure 40. Americas Felodipine Sustained-Release Tablet Consumption Market Share by Application in 2019
Figure 41. United States Felodipine Sustained-Release Tablet Consumption Growth 2015-2020 (K Units)
Figure 42. United States Felodipine Sustained-Release Tablet Value Growth 2015-2020 ($ Millions)
Figure 43. Canada Felodipine Sustained-Release Tablet Consumption Growth 2015-2020 (K Units)
Figure 44. Canada Felodipine Sustained-Release Tablet Value Growth 2015-2020 ($ Millions)
Figure 45. Mexico Felodipine Sustained-Release Tablet Consumption Growth 2015-2020 (K Units)
Figure 46. Mexico Felodipine Sustained-Release Tablet Value Growth 2015-2020 ($ Millions)
Figure 47. APAC Felodipine Sustained-Release Tablet Consumption Market Share by Countries in 2019
Figure 48. APAC Felodipine Sustained-Release Tablet Value Market Share by Regions in 2019
Figure 49. APAC Felodipine Sustained-Release Tablet Consumption Market Share by Type in 2019
Figure 50. APAC Felodipine Sustained-Release Tablet Consumption Market Share by Application in 2019
Figure 51. China Felodipine Sustained-Release Tablet Consumption Growth 2015-2020 (K Units)
Figure 52. China Felodipine Sustained-Release Tablet Value Growth 2015-2020 ($ Millions)
Figure 53. Japan Felodipine Sustained-Release Tablet Consumption Growth 2015-2020 (K Units)
Figure 54. Japan Felodipine Sustained-Release Tablet Value Growth 2015-2020 ($ Millions)
Figure 55. Korea Felodipine Sustained-Release Tablet Consumption Growth 2015-2020 (K Units)
Figure 56. Korea Felodipine Sustained-Release Tablet Value Growth 2015-2020 ($ Millions)
Figure 57. Southeast Asia Felodipine Sustained-Release Tablet Consumption Growth 2015-2020 (K Units)
Figure 58. Southeast Asia Felodipine Sustained-Release Tablet Value Growth 2015-2020 ($ Millions)
Figure 59. India Felodipine Sustained-Release Tablet Consumption Growth 2015-2020 (K Units)
Figure 60. India Felodipine Sustained-Release Tablet Value Growth 2015-2020 ($ Millions)
Figure 61. Australia Felodipine Sustained-Release Tablet Consumption Growth 2015-2020 (K Units)
Figure 62. Australia Felodipine Sustained-Release Tablet Value Growth 2015-2020 ($ Millions)
Figure 63. Europe Felodipine Sustained-Release Tablet Consumption Market Share by Countries in 2019
Figure 64. Europe Felodipine Sustained-Release Tablet Value Market Share by Countries in 2019
Figure 65. Europe Felodipine Sustained-Release Tablet Consumption Market Share by Type in 2019
Figure 66. Europe Felodipine Sustained-Release Tablet Consumption Market Share by Application in 2019
Figure 67. Germany Felodipine Sustained-Release Tablet Consumption Growth 2015-2020 (K Units)
Figure 68. Germany Felodipine Sustained-Release Tablet Value Growth 2015-2020 ($ Millions)
Figure 69. France Felodipine Sustained-Release Tablet Consumption Growth 2015-2020 (K Units)
Figure 70. France Felodipine Sustained-Release Tablet Value Growth 2015-2020 ($ Millions)
Figure 71. UK Felodipine Sustained-Release Tablet Consumption Growth 2015-2020 (K Units)
Figure 72. UK Felodipine Sustained-Release Tablet Value Growth 2015-2020 ($ Millions)
Figure 73. Italy Felodipine Sustained-Release Tablet Consumption Growth 2015-2020 (K Units)
Figure 74. Italy Felodipine Sustained-Release Tablet Value Growth 2015-2020 ($ Millions)
Figure 75. Russia Felodipine Sustained-Release Tablet Consumption Growth 2015-2020 (K Units)
Figure 76. Russia Felodipine Sustained-Release Tablet Value Growth 2015-2020 ($ Millions)
Figure 77. Middle East & Africa Felodipine Sustained-Release Tablet Consumption Market Share by Countries in 2019
Figure 78. Middle East & Africa Felodipine Sustained-Release Tablet Value Market Share by Countries in 2019
Figure 79. Middle East & Africa Felodipine Sustained-Release Tablet Consumption Market Share by Type in 2019
Figure 80. Middle East & Africa Felodipine Sustained-Release Tablet Consumption Market Share by Application in 2019
Figure 81. Egypt Felodipine Sustained-Release Tablet Consumption Growth 2015-2020 (K Units)
Figure 82. Egypt Felodipine Sustained-Release Tablet Value Growth 2015-2020 ($ Millions)
Figure 83. South Africa Felodipine Sustained-Release Tablet Consumption Growth 2015-2020 (K Units)
Figure 84. South Africa Felodipine Sustained-Release Tablet Value Growth 2015-2020 ($ Millions)
Figure 85. Israel Felodipine Sustained-Release Tablet Consumption Growth 2015-2020 (K Units)
Figure 86. Israel Felodipine Sustained-Release Tablet Value Growth 2015-2020 ($ Millions)
Figure 87. Turkey Felodipine Sustained-Release Tablet Consumption Growth 2015-2020 (K Units)
Figure 88. Turkey Felodipine Sustained-Release Tablet Value Growth 2015-2020 ($ Millions)
Figure 89. GCC Countries Felodipine Sustained-Release Tablet Consumption Growth 2015-2020 (K Units)
Figure 90. GCC Countries Felodipine Sustained-Release Tablet Value Growth 2015-2020 ($ Millions)
Figure 91. Global Felodipine Sustained-Release Tablet Consumption Growth Rate Forecast (2021-2025) (K Units)
Figure 92. Global Felodipine Sustained-Release Tablet Value Growth Rate Forecast (2021-2025) ($ Millions)
Figure 93. Americas Felodipine Sustained-Release Tablet Consumption 2021-2025 (K Units)
Figure 94. Americas Felodipine Sustained-Release Tablet Value 2021-2025 ($ Millions)
Figure 95. APAC Felodipine Sustained-Release Tablet Consumption 2021-2025 (K Units)
Figure 96. APAC Felodipine Sustained-Release Tablet Value 2021-2025 ($ Millions)
Figure 97. Europe Felodipine Sustained-Release Tablet Consumption 2021-2025 (K Units)
Figure 98. Europe Felodipine Sustained-Release Tablet Value 2021-2025 ($ Millions)
Figure 99. Middle East & Africa Felodipine Sustained-Release Tablet Consumption 2021-2025 (K Units)
Figure 100. Middle East & Africa Felodipine Sustained-Release Tablet Value 2021-2025 ($ Millions)
Figure 101. United States Felodipine Sustained-Release Tablet Consumption 2021-2025 (K Units)
Figure 102. United States Felodipine Sustained-Release Tablet Value 2021-2025 ($ Millions)
Figure 103. Canada Felodipine Sustained-Release Tablet Consumption 2021-2025 (K Units)
Figure 104. Canada Felodipine Sustained-Release Tablet Value 2021-2025 ($ Millions)
Figure 105. Mexico Felodipine Sustained-Release Tablet Consumption 2021-2025 (K Units)
Figure 106. Mexico Felodipine Sustained-Release Tablet Value 2021-2025 ($ Millions)
Figure 107. Brazil Felodipine Sustained-Release Tablet Consumption 2021-2025 (K Units)
Figure 108. Brazil Felodipine Sustained-Release Tablet Value 2021-2025 ($ Millions)
Figure 109. China Felodipine Sustained-Release Tablet Consumption 2021-2025 (K Units)
Figure 110. China Felodipine Sustained-Release Tablet Value 2021-2025 ($ Millions)
Figure 111. Japan Felodipine Sustained-Release Tablet Consumption 2021-2025 (K Units)
Figure 112. Japan Felodipine Sustained-Release Tablet Value 2021-2025 ($ Millions)
Figure 113. Korea Felodipine Sustained-Release Tablet Consumption 2021-2025 (K Units)
Figure 114. Korea Felodipine Sustained-Release Tablet Value 2021-2025 ($ Millions)
Figure 115. Southeast Asia Felodipine Sustained-Release Tablet Consumption 2021-2025 (K Units)
Figure 116. Southeast Asia Felodipine Sustained-Release Tablet Value 2021-2025 ($ Millions)
Figure 117. India Felodipine Sustained-Release Tablet Consumption 2021-2025 (K Units)
Figure 118. India Felodipine Sustained-Release Tablet Value 2021-2025 ($ Millions)
Figure 119. Australia Felodipine Sustained-Release Tablet Consumption 2021-2025 (K Units)
Figure 120. Australia Felodipine Sustained-Release Tablet Value 2021-2025 ($ Millions)
Figure 121. Germany Felodipine Sustained-Release Tablet Consumption 2021-2025 (K Units)
Figure 122. Germany Felodipine Sustained-Release Tablet Value 2021-2025 ($ Millions)
Figure 123. France Felodipine Sustained-Release Tablet Consumption 2021-2025 (K Units)
Figure 124. France Felodipine Sustained-Release Tablet Value 2021-2025 ($ Millions)
Figure 125. UK Felodipine Sustained-Release Tablet Consumption 2021-2025 (K Units)
Figure 126. UK Felodipine Sustained-Release Tablet Value 2021-2025 ($ Millions)
Figure 127. Italy Felodipine Sustained-Release Tablet Consumption 2021-2025 (K Units)
Figure 128. Italy Felodipine Sustained-Release Tablet Value 2021-2025 ($ Millions)
Figure 129. Russia Felodipine Sustained-Release Tablet Consumption 2021-2025 (K Units)
Figure 130. Russia Felodipine Sustained-Release Tablet Value 2021-2025 ($ Millions)
Figure 131. Spain Felodipine Sustained-Release Tablet Consumption 2021-2025 (K Units)
Figure 132. Spain Felodipine Sustained-Release Tablet Value 2021-2025 ($ Millions)
Figure 133. Egypt Felodipine Sustained-Release Tablet Consumption 2021-2025 (K Units)
Figure 134. Egypt Felodipine Sustained-Release Tablet Value 2021-2025 ($ Millions)
Figure 135. South Africa Felodipine Sustained-Release Tablet Consumption 2021-2025 (K Units)
Figure 136. South Africa Felodipine Sustained-Release Tablet Value 2021-2025 ($ Millions)
Figure 137. Israel Felodipine Sustained-Release Tablet Consumption 2021-2025 (K Units)
Figure 138. Israel Felodipine Sustained-Release Tablet Value 2021-2025 ($ Millions)
Figure 139. Turkey Felodipine Sustained-Release Tablet Consumption 2021-2025 (K Units)
Figure 140. Turkey Felodipine Sustained-Release Tablet Value 2021-2025 ($ Millions)
Figure 141. GCC Countries Felodipine Sustained-Release Tablet Consumption 2021-2025 (K Units)
Figure 142. GCC Countries Felodipine Sustained-Release Tablet Value 2021-2025 ($ Millions)
Figure 143. Astrazeneca Felodipine Sustained-Release Tablet Market Share (2018-2020)
Figure 144. NanJing Easeheal Phaemaecutical Felodipine Sustained-Release Tablet Market Share (2018-2020)
Figure 145. Lifeon Felodipine Sustained-Release Tablet Market Share (2018-2020)
Figure 146. Changzhou Siyao Pharmaceutical Felodipine Sustained-Release Tablet Market Share (2018-2020)
Figure 147. SHANXI KANGBO BIOLOGICAL PRODUCT Felodipine Sustained-Release Tablet Market Share (2018-2020)
Figure 148. Mylan Felodipine Sustained-Release Tablet Market Share (2018-2020)
Figure 149. Sandoz Felodipine Sustained-Release Tablet Market Share (2018-2020)
Please feel free to write an email to us or to use our electronic ticketing system.
